These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21678127)

  • 1. FGF and ERK signaling coordinately regulate mineralization-related genes and play essential roles in osteocyte differentiation.
    Kyono A; Avishai N; Ouyang Z; Landreth GE; Murakami S
    J Bone Miner Metab; 2012 Jan; 30(1):19-30. PubMed ID: 21678127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Phosphate Induces the Expression of Dentin Matrix Protein 1 Through the FGF Receptor in Osteoblasts.
    Nishino J; Yamazaki M; Kawai M; Tachikawa K; Yamamoto K; Miyagawa K; Kogo M; Ozono K; Michigami T
    J Cell Biochem; 2017 May; 118(5):1151-1163. PubMed ID: 27639037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.
    Martin A; Liu S; David V; Li H; Karydis A; Feng JQ; Quarles LD
    FASEB J; 2011 Aug; 25(8):2551-62. PubMed ID: 21507898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF2 alters expression of the pyrophosphate/phosphate regulating proteins, PC-1, ANK and TNAP, in the calvarial osteoblastic cell line, MC3T3E1(C4).
    Hatch NE; Nociti F; Swanson E; Bothwell M; Somerman M
    Connect Tissue Res; 2005; 46(4-5):184-92. PubMed ID: 16546821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular matrix mineralization promotes E11/gp38 glycoprotein expression and drives osteocytic differentiation.
    Prideaux M; Loveridge N; Pitsillides AA; Farquharson C
    PLoS One; 2012; 7(5):e36786. PubMed ID: 22586496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear fibroblast growth factor 2 (FGF2) isoforms inhibit bone marrow stromal cell mineralization through FGF23/FGFR/MAPK in vitro.
    Xiao L; Esliger A; Hurley MM
    J Bone Miner Res; 2013 Jan; 28(1):35-45. PubMed ID: 22836867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 2 and forskolin induce mineralization-associated genes in two kinds of osteoblast-like cells.
    Nakayama Y; Yang L; Takai H; Kaneko H; Abiko Y; Ogata Y
    J Oral Sci; 2012 Sep; 54(3):251-9. PubMed ID: 23047036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of an osteocyte-like phenotype by fibroblast growth factor-2.
    Gupta RR; Yoo DJ; Hebert C; Niger C; Stains JP
    Biochem Biophys Res Commun; 2010 Nov; 402(2):258-64. PubMed ID: 20934405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.
    Rhee Y; Bivi N; Farrow E; Lezcano V; Plotkin LI; White KE; Bellido T
    Bone; 2011 Oct; 49(4):636-43. PubMed ID: 21726676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time lapse imaging techniques for comparison of mineralization dynamics in primary murine osteoblasts and the late osteoblast/early osteocyte-like cell line MLO-A5.
    Dallas SL; Veno PA; Rosser JL; Barragan-Adjemian C; Rowe DW; Kalajzic I; Bonewald LF
    Cells Tissues Organs; 2009; 189(1-4):6-11. PubMed ID: 18728354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
    Mansukhani A; Bellosta P; Sahni M; Basilico C
    J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF2 stimulates osteogenic differentiation through ERK induced TAZ expression.
    Byun MR; Kim AR; Hwang JH; Kim KM; Hwang ES; Hong JH
    Bone; 2014 Jan; 58():72-80. PubMed ID: 24125755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Osteogenic Cell Line That Differentiates Into GFP-Tagged Osteocytes and Forms Mineral With a Bone-Like Lacunocanalicular Structure.
    Wang K; Le L; Chun BM; Tiede-Lewis LM; Shiflett LA; Prideaux M; Campos RS; Veno PA; Xie Y; Dusevich V; Bonewald LF; Dallas SL
    J Bone Miner Res; 2019 Jun; 34(6):979-995. PubMed ID: 30882939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of mRNA expression of matrix extracellular phosphoglycoprotein (MEPE)/ osteoblast/osteocyte factor 45 (OF45) by fibroblast growth factor 2 in cultures of rat bone marrow-derived osteoblastic cells.
    Zhang GX; Mizuno M; Tsuji K; Tamura M
    Endocrine; 2004 Jun; 24(1):15-24. PubMed ID: 15249699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
    Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
    Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes.
    Hirao M; Hashimoto J; Yamasaki N; Ando W; Tsuboi H; Myoui A; Yoshikawa H
    J Bone Miner Metab; 2007; 25(5):266-76. PubMed ID: 17704991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute-phase protein serum amyloid A3 is a novel paracrine coupling factor that controls bone homeostasis.
    Thaler R; Sturmlechner I; Spitzer S; Riester SM; Rumpler M; Zwerina J; Klaushofer K; van Wijnen AJ; Varga F
    FASEB J; 2015 Apr; 29(4):1344-59. PubMed ID: 25491310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism.
    Atkins GJ; Rowe PS; Lim HP; Welldon KJ; Ormsby R; Wijenayaka AR; Zelenchuk L; Evdokiou A; Findlay DM
    J Bone Miner Res; 2011 Jul; 26(7):1425-36. PubMed ID: 21312267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteocyte-specific deletion of Fgfr1 suppresses FGF23.
    Xiao Z; Huang J; Cao L; Liang Y; Han X; Quarles LD
    PLoS One; 2014; 9(8):e104154. PubMed ID: 25089825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF23 Neutralizing Antibody Partially Improves Bone Mineralization Defect of HMWFGF2 Isoforms in Transgenic Female Mice.
    Xiao L; Homer-Bouthiette C; Hurley MM
    J Bone Miner Res; 2018 Jul; 33(7):1347-1361. PubMed ID: 29502359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.